Oberweis Asset Management Inc. lifted its position in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 20.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 156,680 shares of the medical instruments supplier's stock after buying an additional 26,180 shares during the period. ICU Medical makes up about 1.1% of Oberweis Asset Management Inc.'s investment portfolio, making the stock its 12th biggest position. Oberweis Asset Management Inc. owned approximately 0.64% of ICU Medical worth $24,312,000 at the end of the most recent reporting period.
Several other large investors also recently modified their holdings of the company. Harvest Fund Management Co. Ltd bought a new position in ICU Medical in the 4th quarter worth $33,000. Murphy & Mullick Capital Management Corp purchased a new position in shares of ICU Medical during the 4th quarter valued at about $52,000. Venturi Wealth Management LLC grew its stake in shares of ICU Medical by 64.0% during the 4th quarter. Venturi Wealth Management LLC now owns 528 shares of the medical instruments supplier's stock valued at $82,000 after acquiring an additional 206 shares during the period. Russell Investments Group Ltd. increased its holdings in ICU Medical by 88.8% in the 4th quarter. Russell Investments Group Ltd. now owns 638 shares of the medical instruments supplier's stock worth $99,000 after acquiring an additional 300 shares in the last quarter. Finally, Sterling Capital Management LLC raised its stake in ICU Medical by 813.5% during the 4th quarter. Sterling Capital Management LLC now owns 676 shares of the medical instruments supplier's stock worth $105,000 after acquiring an additional 602 shares during the period. Institutional investors own 96.10% of the company's stock.
ICU Medical Trading Up 0.2 %
NASDAQ:ICUI traded up $0.24 on Monday, reaching $135.90. 297,693 shares of the company's stock were exchanged, compared to its average volume of 274,101. The firm has a market capitalization of $3.34 billion, a price-to-earnings ratio of -29.74 and a beta of 0.86. ICU Medical, Inc. has a 52-week low of $95.44 and a 52-week high of $196.26. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75. The business has a fifty day moving average of $143.81 and a 200-day moving average of $157.93.
Analyst Upgrades and Downgrades
ICUI has been the subject of a number of recent analyst reports. Raymond James set a $97.00 price target on shares of ICU Medical in a research report on Wednesday, March 12th. StockNews.com lowered ICU Medical from a "buy" rating to a "hold" rating in a research note on Thursday. KeyCorp lowered their target price on ICU Medical from $209.00 to $191.00 and set an "overweight" rating for the company in a report on Monday, April 21st. Finally, Needham & Company LLC reaffirmed a "hold" rating on shares of ICU Medical in a research report on Tuesday, April 8th. Two equities research analysts have rated the stock with a hold rating, two have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $162.67.
Read Our Latest Report on ICU Medical
About ICU Medical
(
Free Report)
ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.
See Also

Before you consider ICU Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ICU Medical wasn't on the list.
While ICU Medical currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.